In patient-derived xenograft (PDX) mouse models, treatment with EGFR-specific CAR-T cells inhibited tumor growth without affecting body weight, demonstrating their potential efficacy against TNBC (Table 3) [244]. This evidence concerns the gene EGFR and neoplasm.